Coeliac Disease Trial, Recruiting (NCT07039773)

Coeliac Disease Trial, Recruiting NCT07039773 Sponsor: Oslo University Hospital Condition: Coeliac Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07039773 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Coeliac Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your body weight is in a healthy range for your height (specifically, your BMI is between 18 and 33)
You are willing to follow the study procedures and have signed a written consent form agreeing to take part
You were diagnosed with coeliac disease as a child, confirmed by blood tests and a small intestine biopsy that showed damage to the gut lining
You have been strictly following a gluten-free diet for at least the last 12 months

Who may not be able to join:

Your most recent blood test at the screening visit shows signs that coeliac disease may still be active (confirm with trial site)
You are currently pregnant or breastfeeding; women who could become pregnant must be using reliable contraception
You have another ongoing inflammatory or long-term health condition, such as uncontrolled underactive thyroid, type 1 diabetes, heart disease, kidney problems, or inflammatory bowel disease (confirm with trial site if you are unsure whether your condition applies)
You are currently taking medications that suppress the immune system or steroids
You have an allergy to wheat
You currently have a serious acute infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07039773

Sponsor: Oslo University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Coeliac Disease

More information: https://clinicaltrials.gov/study/NCT07039773

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your body weight is in a healthy range for your height (specifically, your BMI is between 18 and 33)
You are willing to follow the study procedures and have signed a written consent form agreeing to take part
You were diagnosed with coeliac disease as a child, confirmed by blood tests and a small intestine biopsy that showed damage to the gut lining
You have been strictly following a gluten-free diet for at least the last 12 months

Who may not be able to join:

Your most recent blood test at the screening visit shows signs that coeliac disease may still be active (confirm with trial site)
You are currently pregnant or breastfeeding; women who could become pregnant must be using reliable contraception
You have another ongoing inflammatory or long-term health condition, such as uncontrolled underactive thyroid, type 1 diabetes, heart disease, kidney problems, or inflammatory bowel disease (confirm with trial site if you are unsure whether your condition applies)
You are currently taking medications that suppress the immune system or steroids
You have an allergy to wheat
You currently have a serious acute infection

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oslo University Hospital

Registry

ClinicalTrials.gov

Start date

1 August 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Comparison of serum IL-2 response rates between the gluten shake group and the cookie group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov